We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Hmtase Inhibitor Ix mm-102
List Price $305.08 Your Price $305.08
Sigma-Aldrich Hmtase Inhibitor Ix mm-102 1pc X 10mg - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-5006490001
MFG.PART: 5006490001
UNSPSC: 12352200
Manufacturer: Sigma-Aldrich


Assay
≥95% (HPLC)
Quality Level
100
Form
powder
Potency
1 nM Ki
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
desiccated (hygroscopic)
protect from light
Color
light beige
Solubility
DMSO: 100 mg/mL
Storage Temp.
−20°C
General Description
A cell-permeable peptidomimetic that competes against MLL1 (Mixed Lineage Leukemia 1) minimum essential WIN (WDR5 INteracting) motif (-Ala3764-Arg-Ala3766-) for WDR5 (Trp-Asp Repeat Domain 5) binding (IC50/Ki= 2.5 nM/<1 nM and 540 nM/120 nM, respectively), effectively preventing MLL1 from complex assembling with WDR5, RbBP5 (Retinoblastoma Binding Protein 5), and ASH2L (Absent Small or Homeotic-2-Like) for enhanced H3K4 methyltransferase activity (IC50= 0.4 nM). Shown to reduceHoxA9andMeis-1mRNA expression (by 76% and 36%, respectively, after 96 H 50 µM mm-102 treatment) in myeloblasts derived fromMLL1-AF9-transduced murine bone marrow cells and preferentially inhibit the growth of MLL1-AF4-harboring MV4;11 and MLL1-ENL-harboring KOPN8 leukemia cultures (GI50in 7 days = 25 µM) via apoptosis induction (by >75% in 4 days in MV4:11 cultures; 50 µM mm-102), while exhibiting much reduced potency against BCR-ABL-dependent K562 cells (GI50in 7 days = 84 µM; >90 live cells after 4-day 50 µM mm-102 treatment).A cell-permeable peptidomimetic that prevents MLL1 (Mixed Lineage Leukemia 1) from complex assembling with WDR5 (Trp-Asp Repeat Domain 5), RbBP5 (Retinoblastoma Binding Protein 5), and ASH2L (Absent Small or Homeotic-2-Like) for enhanced H3K4 methyltransferase activity (IC50= 0.4 nM). Shown to reduceHoxA9andMeis-1mRNA expression in myeloblasts derived fromMLL1-AF9-transduced murine bone marrow cells (50 µM for 96 H) and preferentially inhibit the growth of MLL1-AF4-harboring MV4;11 and MLL1-ENL-harboring KOPN8 leukemia cultures (GI50in 7 days = 25 µM) via apoptosis induction, while exhibiting much reduced potency against BCR-ABL-dependent K562 cells (GI50in 7 days = 84 µM).Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without water.
Biochem/Physiol Actions
Cell permeable: yesPrimary TargetWDR5Reversible: yes
Packaging
Packaged under inert gasWarning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.Use only fresh DMSO for reconstitution.Other Notes
Karatas, H., et Al. 2013.J. Am. Chem. Soc. 135,669.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany| SKU | SIAL-5006490001 |
|---|---|
| Supplier Part Number | 5006490001 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 10.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

